Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol Injection for Benign Cystic Thyroid Nodules
NCT03257930Phase 1Completed
- Start
- Aug 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ethanol in thyroid nodule. Primary endpoint: Reduction of volume of the cyst at 6 months. Started Aug 2017; status: completed.
02
Drugs
ethanol
03
Conditions
thyroid nodule
Beyond the preview
Go deeper on NCT03257930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03257930.